FDA Review ADHD Drugs Induce-Psychosis, Mania, Homicide, Suicide
Psychiatric Adverse Events Associated with Drug Treatment of ADHD: Review of Postmarketing Safety Data
FDA Psychopharm Advisory Chair Acknowledges No Evidence for SSRI Chemical Imbalance Claims_CMAJ
"Biological psychiatrists have looked very closely for a serotonin imbalance or dysfunction in patients with depression or obsessive compulsive disorder and, to date, it has been elusive," says Dr. Wayne Goodman, Chair of the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee.
Grassley to HHS Secretary: OHRP calls Blood Experiment UNETHICAL, Unapprovable
In a blistering letter addressed to the Secretary of Health and Human Services, Senator Grassley calls upon Michael Leavitt to give “immediate attention” to the serious issues raised by a Northfield Laboratory, non-consensual artificial blood experiment.
Fix the Diagnosis, Not the Children
From both sides of the Atlantic, even psychiatrists are acknowledging–the ADHD diagnosis makes no sense.
FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug
“When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease. Last year, she died at the age of 46 from an infection linked to the drug.”
ADHD Drugs Addictive_NIDA study
"More than 7 million americans are estimated to have misused stimulant drugs."
ADHD Drug Risks: Cardiovascular and Cerebrovascular Problems
"This is out-of-control use of drugs that have profound cardiovascular consequences. We have got a potential public health crisis. I think patients and families need to be made aware of these concerns."
Which is it—51 or 186 deaths linked to ADHD drugs?
Children have been dying from exposure to psychostimulant drugs as the FDA looked the other way:
Drug Safety Issues-IOM Panel Blasts FDA Advisory Committee Process
IOM committee members were highly critical of FDA’s advisory panels that regularly “recommend” approval without analyzing the safety data.
FDA: NIMH SSRI Study Flawed–No Comparative Untreated Group
Even Dr. Robet Temple, FDA Medical Policy Director of the Center for Drug Evaluation & Research dismisses the claimed finidings of a flawed, but highly trumpeted recent SSRI study published in the American Journal of Psychiatry. The study was sponsored by the National Institute of Mental Health.
FDA SSRI Warning
" A causal role for antidepressants in inducing suicidality has been established in pediatric patients."
Gov Accountability Project Creates "FactSquad" on Rx Drugs
Gov Accountability Project Creates “FactSquad” on Rx Drugs December 11, 2005 In the wake of the credibility crisis public trust in the safety of FDA-approved prescription drugs is eroded. The Government Accounability Project (GAP) has established a “Fact Squad” to challenge poor performance; in particular, FDA’s failure to protect the…